We aim to explore the diagnostic and prognostic role in multiple sclerosis of two biomarkers, i.e. immunoglobulin free light chains and complement activation products, and to identify predictors of silent progression.
Projet mené par by Serena Borrelli.
Soutien
79.000 €
Restez informé.e des nouveaux individus ou organisations soutenus
